Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease.

Anila DuniAthanasios KitsosAris BechlioulisGeorgios S MarkopoulosLampros LakkasGerasimos BaxevanosMichail MitsisGeorge Vartholomatos Katerina K Naka Evangelia Dounousi

Published in: Biomedicines (2023)

Patients with CRS-2 exhibit alterations in immune cell profile compared to CKD patients of similar kidney function but without CVD. In the CRS-2 cohort, CD4+ T-lymphocytes independently predicted fatal cardiovascular events.

Keyphrases

end stage renal disease
chronic kidney disease
cardiovascular disease
cardiovascular events
ejection fraction
newly diagnosed
prognostic factors
type diabetes
patient reported outcomes
case report